Company news

Helix BioPharma Corp. news in 2024

Helix BioPharma Corp.'s news releases, calls and decks from 2024, newest first.

View company

Helix BioPharma Corp. Appoints James B. Murphy as Chief Financial Officer

December 11, 2024

Helix BioPharma Amends Acquisition Agreements to Finalise Share Consideration Ahead of Potential Financing

December 6, 2024

Helix Biopharma Corp. Enters into Asset Purchase Agreement to Acquire Oral Gemcitabine Chemotherapy Compound

December 2, 2024

Helix Biopharma Corp. Enters into Asset Purchase Agreement to Acquire Oral Immune Checkpoint Inhibitor and Expand Immune-Oncology Portfolio

November 29, 2024

Helix Biopharma Corp. Announces Issuance of U.S. Patent

November 21, 2024

Helix BioPharma Corp. Attends World ADC San Diego

November 11, 2024

Helix Biopharma Corp. Announces CFO and Corporate Secretary Resignation

November 8, 2024

Helix BioPharma Corp. Reports Voting Results

January 18, 2024

Decks in 2024